United States · Bill · HR
H.R. 916 (103rd)
Prescription Drug Prices Review Board Act of 1993
Introduced
16 February 1993
Last action
—
Status
Sponsor introductory remarks on measure. (CR E1889)
Sponsors
—
Subjects
Discovery layer
Source updated
3 June 2026
Summary
Prescription Drug Prices Review Board Act of 1993 - Establishes in the Food and Drug Administration the Patented Medicine Prices Review Board which shall have the power to decrease the length of term of a prescription drug patent if, after notice and a hearing, it is found that the drug's price is excessive. Defines the term excessive price. Allows the Board to require the recapture of tax benefits provided to the patentee of an excessively priced drug.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 28 February 1994
Introduced in House (PDF)
Introduced in House · EN · 28 February 1994
Introduced in House
summary · EN · 16 February 1993
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/103rd-congress/house-bill/916
- Open data entity: https://api.congress.gov/v3/bill/103/hr/916